154 related articles for article (PubMed ID: 35064064)
1. AHRR (cg05575921) Methylation Safely Improves Specificity of Lung Cancer Screening Eligibility Criteria: A Cohort Study.
Jacobsen KK; Schnohr P; Jensen GB; Bojesen SE
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):758-765. PubMed ID: 35064064
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a simple general population lung cancer risk model including AHRR-methylation.
Jacobsen KK; Kobylecki CJ; Skov-Jeppesen SM; Bojesen SE
Lung Cancer; 2023 Jul; 181():107229. PubMed ID: 37150141
[TBL] [Abstract][Full Text] [Related]
3.
Bojesen SE; Timpson N; Relton C; Davey Smith G; Nordestgaard BG
Thorax; 2017 Jul; 72(7):646-653. PubMed ID: 28100713
[TBL] [Abstract][Full Text] [Related]
4. AHRR methylation in heavy smokers: associations with smoking, lung cancer risk, and lung cancer mortality.
Grieshober L; Graw S; Barnett MJ; Thornquist MD; Goodman GE; Chen C; Koestler DC; Marsit CJ; Doherty JA
BMC Cancer; 2020 Sep; 20(1):905. PubMed ID: 32962699
[TBL] [Abstract][Full Text] [Related]
5. AHRR (cg05575921) methylation extent of leukocyte DNA and lung cancer survival.
Kemp Jacobsen K; Johansen JS; Mellemgaard A; Bojesen SE
PLoS One; 2019; 14(2):e0211745. PubMed ID: 30730943
[TBL] [Abstract][Full Text] [Related]
6. Methylation at cg05575921 of a smoking-related gene (AHRR) in non-smoking Taiwanese adults residing in areas with different PM
Tantoh DM; Lee KJ; Nfor ON; Liaw YC; Lin C; Chu HW; Chen PH; Hsu SY; Liu WH; Ho CC; Lung CC; Wu MF; Liaw YC; Debnath T; Liaw YP
Clin Epigenetics; 2019 May; 11(1):69. PubMed ID: 31060609
[TBL] [Abstract][Full Text] [Related]
7. Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.
Li K; Hüsing A; Sookthai D; Bergmann M; Boeing H; Becker N; Kaaks R
Cancer Prev Res (Phila); 2015 Sep; 8(9):777-85. PubMed ID: 26076698
[TBL] [Abstract][Full Text] [Related]
8. AHRR hypomethylation as an epigenetic marker of smoking history predicts risk of myocardial infarction in former smokers.
Langsted A; Bojesen SE; Stroes ESG; Nordestgaard BG
Atherosclerosis; 2020 Nov; 312():8-15. PubMed ID: 32947224
[TBL] [Abstract][Full Text] [Related]
9. AHRR cg05575921 methylation in relation to smoking and PM
Tantoh DM; Wu MC; Chuang CC; Chen PH; Tyan YS; Nfor ON; Lu WY; Liaw YP
Clin Epigenetics; 2020 Jul; 12(1):117. PubMed ID: 32736658
[TBL] [Abstract][Full Text] [Related]
10. Enhanced selection of people for lung cancer screening using AHRR (cg05575921) or F2RL3 (cg03636183) methylation as biological markers of smoking exposure.
Bhardwaj M; Schöttker B; Holleczek B; Brenner H
Cancer Commun (Lond); 2023 Aug; 43(8):956-959. PubMed ID: 37278142
[No Abstract] [Full Text] [Related]
11. Using Cg05575921 methylation to predict lung cancer risk: a potentially bias-free precision epigenetics approach.
Philibert R; Dawes K; Moody J; Hoffman R; Sieren J; Long J
Epigenetics; 2022 Dec; 17(13):2096-2108. PubMed ID: 35920547
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of
Bravo-Gutiérrez OA; Falfán-Valencia R; Ramírez-Venegas A; Sansores RH; Hernández-Zenteno RJ; Hernández-Pérez A; García-Gómez L; Osio-Echánove J; Abarca-Rojano E; Pérez-Rubio G
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440450
[TBL] [Abstract][Full Text] [Related]
13. Smoking-associated DNA methylation markers predict lung cancer incidence.
Zhang Y; Elgizouli M; Schöttker B; Holleczek B; Nieters A; Brenner H
Clin Epigenetics; 2016; 8():127. PubMed ID: 27924164
[TBL] [Abstract][Full Text] [Related]
14.
Kodal JB; Kobylecki CJ; Vedel-Krogh S; Nordestgaard BG; Bojesen SE
Eur Respir J; 2018 Mar; 51(3):. PubMed ID: 29348151
[TBL] [Abstract][Full Text] [Related]
15. Changing Smoking Behavior and Epigenetics: A Longitudinal Study of 4,432 Individuals From the General Population.
Skov-Jeppesen SM; Kobylecki CJ; Jacobsen KK; Bojesen SE
Chest; 2023 Jun; 163(6):1565-1575. PubMed ID: 36621758
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation of the cancer-related genes F2RL3 and AHRR is associated with occupational exposure to polycyclic aromatic hydrocarbons.
Alhamdow A; Lindh C; Hagberg J; Graff P; Westberg H; Krais AM; Albin M; Gustavsson P; Tinnerberg H; Broberg K
Carcinogenesis; 2018 Jul; 39(7):869-878. PubMed ID: 29722794
[TBL] [Abstract][Full Text] [Related]
17. DNA Methylation of the Aryl Hydrocarbon Receptor Repressor Associations With Cigarette Smoking and Subclinical Atherosclerosis.
Reynolds LM; Wan M; Ding J; Taylor JR; Lohman K; Su D; Bennett BD; Porter DK; Gimple R; Pittman GS; Wang X; Howard TD; Siscovick D; Psaty BM; Shea S; Burke GL; Jacobs DR; Rich SS; Hixson JE; Stein JH; Stunnenberg H; Barr RG; Kaufman JD; Post WS; Hoeschele I; Herrington DM; Bell DA; Liu Y
Circ Cardiovasc Genet; 2015 Oct; 8(5):707-16. PubMed ID: 26307030
[TBL] [Abstract][Full Text] [Related]
18. 'Reduced' HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trial.
Røe OD; Markaki M; Tsamardinos I; Lagani V; Nguyen OTD; Pedersen JH; Saghir Z; Ashraf HG
BMJ Open Respir Res; 2019; 6(1):e000512. PubMed ID: 31803478
[TBL] [Abstract][Full Text] [Related]
19. AHRR Methylation is a Significant Predictor of Mortality Risk in Framingham Heart Study.
Philibert RA; Dogan MV; Mills JA; Long JD
J Insur Med; 2019; 48(1):79-89. PubMed ID: 31618096
[No Abstract] [Full Text] [Related]
20. Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort.
Lee DH; Hwang SH; Lim MK; Oh JK; Song DY; Yun EH; Park EY
PLoS One; 2017; 12(4):e0176783. PubMed ID: 28453567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
